Consensus molecular subtypes (CMS) in metastatic colorectal cancer- personalized decision medicine. Radiol Oncol [Internet]. 2020 Sep. 2 [cited 2026 Sep. 22];54(3):272-7. Available from: https://www.radioloncol.com/index.php/ro/article/view/3427